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Abstract 
Drug abuse is a chronic, often relapsing brain disease that causes an individual to seek 
out and use drugs despite the negative consequences. In 2006, an estimated 20.4 million 
Americans aged 12 or older were current illicit drug users (NIDA, 2008).  Drug addiction 
is a major public health problem that impacts all of society including the medical, social, 
criminal, and economic aspects. Annually, abuse and addiction to alcohol, nicotine, and 
illegal substances costs Americans a half trillion dollars and contributes to the death of 
more than 100,000 Americans. Tobacco alone causes an estimated 440,000 deaths per 
year (NIDA, 2008).  Drug addiction is a costly public health problem that often requires 
intervention and treatment in order to help affected individuals break their ties to 
addiction. This paper explores the various causes of drug abuse and compares the 
effectiveness of treatment options that are available to addicts.  Studies of treatment 
options are also examined, most of which indicate that programs that address all of the 
aspects of drug abuse, mental, social and economic problems, will result in the best 
chance of recovery. 
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Introduction 
 
The National Institute on Drug Abuse (NIDA) defines drug dependence as a 
chronic, often relapsing brain disease that causes an individual to seek out and use drugs 
despite the negative consequences. Drug dependence most often begins as the excessive 
use of a psychoactive substance. A psychoactive substance is a chemical that acts 
primarily on the central nervous system (NIDA, 2008). Although substance abuse can be 
damaging, this type of abuse may not initially affect a person’s quality of life or result in 
significant physiological, psychological, or social dysfunction. However, despite these 
seemingly benign consequences, one-half of those who abuse drugs go on to become 
addicted (NIDA, 2008).  Once a person becomes addicted, drug dependence can 
significantly damage an individual’s life, affecting them physically, mentally and 
socially.   
Drug addiction is a chronic disorder, similar to diseases such as Type II diabetes, 
cancer, and cardiovascular disease. Like other chronic disorders, both environment, such 
as family history and peer pressure and genetic factors, such as the predisposition to 
addiction, can lead to drug dependence. In 2006, an estimated 20.4 million Americans 
aged 12 or older were current illicit drug users (NIDA, 2008).  Drug addiction is a major 
public health problem that impacts all of society, including the medical, criminal, 
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economic and social aspects.  Annually, abuse and addiction to alcohol, nicotine, and 
illegal substances costs Americans a half trillion dollars. Yearly, abuse of illicit drugs and 
alcohol contributes to the death of more than 100,000 Americans. Tobacco alone causes 
an estimated 440,000 deaths per year (NIDA, 2008). Clearly, drug addiction is a public 
health issue that needs attention.  It is a costly problem that often requires intervention 
and treatment in order to help affected individuals break their ties to addiction. 
 In order to determine the best type of treatment options for an addict, an 
understanding of drugs and their effect on the individual must be established.  This paper 
will identify drugs of abuse and their usage. It will also discuss how drugs affect the 
body, and most importantly compare treatment options. Since drugs impact all areas of an 
addict’s life, programs that work to treat the entire person and not just the mentality of 
addiction, may be more effective. Programs, such as therapeutic communities, in which 
an addicted individual lives in a drug free environment and receives psychological 
services as well as vocational training, show success in treating and meeting most 
individuals’ needs that enter the program.  The effectiveness of this treatment option and 
other programs such as group meetings and twelve-step programs will be discussed. 
Additionally, studies of treatment options will be examined in order to determine which 
methods show the best potential for sustained recovery. 
 
Drugs of Abuse 
 
A variety of drugs of abuse exist and can be categorized in different ways. The 
Controlled Substances Act of 1970 divided illegal and abused drugs into 5 schedules.  
These schedules, which are enforced by the Drug Enforcement Administration (DEA), 
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are used to govern the legal distribution and use of most substances that are considered to 
have a significant abuse liability. The schedules are as follows: 
 Schedule I substances have a high abuse liability and no approved medical use. 
These substances are available for investigational purposes only, and the research 
protocol must be approved by the Food and Drug Administration (FDA) prior to 
granting a license for handling Schedule I compounds. Manufacturers under 
federal contract provide drugs. Pharmacies do not sell these compounds nor can 
physicians write prescriptions for them. Special record-keeping and storage 
procedures are required for all Schedule I substances.  
 Schedule II-IV substances have decreasing abuse liabilities (II is the highest) 
and approved medical uses. Physicians are licensed to prescribe these compounds 
and pharmacies can dispense them, although pharmacies do not stock all of these 
substances. Schedule II compounds have more stringent record-keeping and 
storage requirements than do Schedule III and IV substances.  
 
 Schedule V substances have a recognized abuse liability (and approved medical 
uses) but are generally not regulated- they are available without prescription. 
Many of these substances are used in common, over-the-counter medicines. 
Including compounds on this schedule facilitates state and local regulations 
deemed appropriate in some jurisdictions. An individual state may impose 
restrictions on some substance considered to have an unexpectedly high abuse 
liability (DEA, 2008). 
Scheduling is not the only method for categorizing drugs. The effect drugs have on 
the body can also be used to make distinctions. Drugs affect the body differently. Some 
drugs act as depressants, while others act as stimulants.  The chart below lists a few of the 
common drugs of abuse, their DEA schedule, how the drug is administered, and the 
effect that each has on the human body. 
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Chart of Common Drugs of Abuse: 
 
Substance: DEA/Schedule and How it is 
Administered: 
Intoxication 
Effects/Consequences: 
Marijuana: 
 
Cannabinoids 
I/swallowed, smoked euphoria, slowed thinking and 
reaction time, confusion, 
impaired balance and 
coordination/cough, frequent 
respiratory infections; 
impaired memory and 
learning; increased heart rate, 
anxiety; panic attacks; 
tolerance, addiction 
Barbiturates: 
 
Depressant 
II, III, V/injected, swallowed  reduced anxiety; feeling of 
well-being; lowered 
inhibitions; slowed pulse and 
breathing; lowered blood 
pressure; poor 
concentration/fatigue; 
confusion; impaired 
coordination, memory, 
judgment; addiction; 
respiratory depression and 
arrest; death 
GHB- gamma- 
hydroxybutyrate:  
Depressant 
I/swallowed drowsiness, nausea/vomiting, 
headache, loss of 
consciousness, loss of 
reflexes, seizures, coma, death 
PCP and analogs-
phencyclidine; angel dust : 
Dissociate Anesthetics 
 
 
 
 
 
 
 
 
 
I, II/injected, swallowed, 
smoked 
PCP and analogs—possible 
decrease in blood pressure 
and heart rate, panic, 
aggression, violence/loss of 
appetite, depression 
LSD-lysergic acid 
diethylamide 
Hallucinogen 
I/swallowed, absorbed through 
mouth tissues 
altered states of perception 
and feeling; nausea; persisting 
perception disorder 
(flashbacks) 
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Substance: DEA/Schedule and How it is 
Administered: 
Intoxication 
Effects/Consequences: 
Codeine: Opioid and 
Morphine Derivatives 
II, III, IV, V/injected, 
swallowed 
 pain relief, euphoria, 
drowsiness/nausea, 
constipation, confusion, 
sedation, respiratory 
depression and arrest, 
tolerance, addiction, 
unconsciousness, coma, death 
Heroin-diacetyl- 
morphine: Opioid and 
Morphine Derivatives 
I/injected, smoked, snorted  pain relief, euphoria, 
drowsiness/nausea, 
constipation, confusion, 
sedation, respiratory 
depression and arrest, 
tolerance, addiction, 
unconsciousness, coma, death, 
and staggering gait 
Amphetamine: Stimulant II/injected, swallowed, 
smoked, snorted 
increased heart rate, blood 
pressure, metabolism; feelings 
of exhilaration, energy, 
increased mental 
alertness/rapid or irregular 
heart beat; reduced appetite, 
weight loss, heart failure, 
nervousness, insomnia 
 
 rapid breathing/tremor, loss 
of coordination; irritability, 
anxiousness, restlessness, 
delirium, panic, paranoia, 
impulsive behavior, 
aggressiveness, tolerance, 
addiction, psychosis 
Cocaine: Stimulant II/injected, smoked, snorted increased temperature/chest 
pain, respiratory failure, 
nausea, abdominal pain, 
strokes, seizures, headaches, 
malnutrition, panic attacks 
MDMA (methylenedioxy- 
methamphetamine-ecstasy: 
Stimulant 
I/swallowed mild hallucinogenic effects, 
increased tactile sensitivity, 
empathic feelings/impaired 
memory and learning, 
hyperthermia, cardiac toxicity, 
renal failure, liver toxicity 
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Substance: DEA/Schedule and How it is 
Administered: 
Intoxication 
Effects/Consequences: 
Methamphetamine: 
Stimulant 
II/injected, swallowed, 
smoked, snorted 
aggression, violence, 
psychotic behavior/memory 
loss, cardiac and neurological 
damage; impaired memory 
and learning, tolerance, 
addiction 
Nicotine not scheduled/smoked, 
snorted, taken in snuff and spit 
tobacco 
additional effects attributable 
to tobacco exposure; adverse 
pregnancy outcomes; chronic 
lung disease, cardiovascular 
disease, stroke, cancer, 
tolerance, addiction 
Inhalants not scheduled/inhaled through 
nose or mouth 
 
 
 
 
 
 
 
 
stimulation, loss of inhibition; 
headache; nausea or 
vomiting; slurred speech, loss 
of motor coordination; 
wheezing/unconsciousness, 
cramps, weight loss, muscle 
weakness, depression, 
memory impairment, damage 
to cardiovascular and nervous 
systems, sudden death 
Anabolic steroids III/injected, swallowed, 
applied to skin 
no intoxication 
effects/hypertension, blood 
clotting and cholesterol 
changes, liver cysts and 
cancer, kidney cancer, 
hostility and aggression, acne; 
in adolescents, premature 
stoppage of growth; in males, 
prostate cancer, reduced sperm 
production, shrunken testicles, 
breast enlargement; in 
females, menstrual 
irregularities, development of 
beard and other masculine 
characteristics 
Adapted from the NIDA Chart for Commonly Abused Drugs. http://www.nida.nih.gov/DrugPages/DrugsofAbuse.html,  2008. 
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The Nature of Addiction 
 
 
 
The Process of Addiction 
Drugs of abuse can affect the brain by mimicking neurotransmitters, as with 
heroin or marijuana or alter neurotransmitter regulation and release, as with cocaine and 
amphetamines. Drugs disrupt normal brain communication. The interruption of the 
brain’s normal neurotransmitter functions eventually lead to addiction; inhibiting an 
individual’s ability to make sound judgments and control actions.  Without these 
regulatory abilities, the drug-addicted person will compulsively choose drugs despite the 
negative consequences (Milhorn, 1990). 
 
Reasons for Using Drugs 
There are a variety of factors that have been identified as reasons for the use of 
drugs, some genetic and some environmental. For example, research among family, 
twins, and adopted children has confirmed that genetics can influence the risk of the 
initial use of a substance. Scientists estimate that genetic factors account for between 40 
and 60 % of a person's vulnerability to addiction, including the effects of the environment 
on gene expression and function (NIDA, 2008). Specifically, genes that affect 
dopaminergic and serotonergic neurotransmisson, linked to high novelty seeking traits, 
have been identified as genetic factors that can increase a person’s chance of initiating 
drug use.  Some studies suggest that this genetic link can also account for the transition 
from drug use to drug addiction.  However, other studies suggest that this link is not as 
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strong as the role environmental factors, such as peer pressure, social acceptance and the 
individual’s own self-efficacy, play in the transition (Galanter and Kleber, 2004).   
 
Environmental Factors 
According to the NIDA, there are several environmental reasons as to why 
people begin to abuse drugs and become addicted.  For example, some people simply 
want to feel good.  Most abused drugs produce intense feelings of pleasure or 
euphoria. This initial sensation of euphoria is followed by other effects, which differ 
with the type of drug used. Stimulants such as cocaine produce a euphoric feeling 
followed by feelings of power, self-confidence, and increased energy. In contrast, the 
euphoria caused by opiates such as heroin, is followed by feelings of relaxation and 
satisfaction. In addition to feeling good, another reason to take drugs is to reduce 
mental stress.  To some, taking drugs relieves social anxiety, stress and depression.  
Stress plays a large role in drug abuse. It can be the reason for initially taking drugs, 
continued drug use and also the reason for relapse after treatment. In addition to taking 
drugs to feel better, some take drugs for performance enhancement. This is the case 
with anabolic steroids. The pressure that some athletes feel to excel in their sport 
sometimes makes them turn to drugs in order to increase their physical ability. 
Additionally, curiosity and peer pressure often cause people to become involved with 
drug use.  Peer pressure can influence adolescents to use drugs in order to be accepted 
by a group.  Pressure or influence to take drugs can also come from the individuals’ 
family. If a child is exposed to drugs or alcohol abuse in the home, he or she may be 
likely to mimic family members and develop an addiction. Another factor that 
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increases the risk for drug abuse includes early use. Although taking drugs at any age 
can lead to addiction, research shows that the earlier a person begins to use drugs, the 
more likely he or she is to progress to more serious abuse. This early use may also be a 
result of early biological and social vulnerability factors, including genetic 
susceptibility, mental illness, unstable family relationships, and exposure to physical 
or sexual abuse.  Finally, the method of administration, smoking and injection 
increases the possibility of addiction. Both smoking and injection allows the drug to 
enter the brain quickly, often within seconds. The abuser receives a powerful rush of 
pleasure that usually fades within a few minutes after taking the drug. As the high 
fades, the abuser begins to experience abnormally low feelings or depression. At this 
point, the abuser recurrently seeks out drugs in order to feel normal again, a process 
that ultimately leads to addiction (NIDA, 2008).  
Prevention is the primary line of defense against drug use. Therefore, an 
increase in protective factors such as self-control, positive relationships, parental 
support, academic competence, anti-drug use policies, and strong community 
attachment can be developed as preventive measures to keep adolescents from 
beginning drug use (NIDA, 2008). In contrast, the lack of these positive preventive 
measures increases the chance of an individual becoming addicted to drugs. When this 
first line of defense fails, the only other option to help an individual into recovery is 
treatment. 
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Drug Use Demographics 
 
 
 
 
Average age of initial use of drugs 
 
Initial drug use usually begins in adolescence. According to a study conducted by 
the Substance Abuse and Mental Health Services Administration (SAMHSA) published 
in the National Survey on Drug Use and Health in 2006, an estimated 2.8 million people 
aged 12 or older used an illicit drug for the first time in 2006. This averages to nearly 
8,000 initiates per day. Additionally, more than half of initiates (57.8 %) were younger 
than age 18 when they first used. The average age at initiation among persons aged 12 to 
49 was 19.0 years.  The specific drug categories with the largest number of recent 
initiates among persons aged 12 or older were non-medical use of pain relievers (2.2 
million) and marijuana use (2.1 million), followed by non-medical use of tranquilizers 
(1.1 million), cocaine (1.0 million), ecstasy (0.9 million), stimulants (0.8 million), and 
inhalants (0.8 million) (National Survey on Drug Use and Health, 2006). 
 
Age and Ethnicity and Drug Use 
Not only do drugs affect people of all ages, they affect people of all ethnic 
backgrounds.  The 2006 National Survey on Drug Use and Health showed that the 
highest rate of current illicit drug use was among American Indian/Alaska Natives 
(13.7%), followed by Blacks/African Americans (9.8%), persons reporting two or more 
races (8.9%), Whites (8.5%), Native Hawaiian/other Pacific Islanders (7.5%), and 
Hispanics (6.9%). The lowest rate of current illicit drug use was among Asians (3.6%).
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Additional studies provide further information about the use of drugs among 
various groups of young people.  The 2005 Youth Risk Behavior Surveillance System 
(YRBSS) study by the Centers for Disease Control and Prevention (CDC) surveyed high 
school students on several risk factors including drug and alcohol use. The 2005 report 
showed that 23.0% of Hispanic, 20.4% of Black, 20.3% of White, and 13.9% of "other" 
race high school students were current marijuana users (YRBSS, 2006). 
Finally, another study conducted on youth and drug use provided an overall 
account of drug use among various groups. According to the 2006 findings from the 
Monitoring the Future Study, African-American 8th, 10th and 12th grade students have 
substantially lower usage rates for most illicit drugs when compared to White students. 
Hispanics generally have rates of use for many drugs that tend to fall between usage rates 
for Whites and Blacks. However, Hispanic seniors have the highest rate of lifetime usage 
of powder cocaine, crack cocaine, heroin, methamphetamine, and crystal 
methamphetamine (Monitoring the Future, 2007).  Although there are some differences 
in drug use among ethnic groups, these statistics indicate abuse does not affect one racial 
or ethnic group substantially more than another. It is a public health problem that equally 
affects everyone. 
 
 
Consequences of Drug Abuse and Dependence 
 
Consequences due to the abuse of drugs come in the form of health related issues 
loss of jobs, friends, family and often freedom.  
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Health Effects 
 
 Drug addiction can lead to a number of health consequences. Drugs can cause 
respiratory, liver, neurological and kidney damage as well as heart attacks and cancer. 
Drug addiction can also lead to an increased risk of contracting an infectious disease such 
as human immunodeficiency virus (HIV) and hepatitis C. Although the before mentioned 
organ damage is important, these disorders are limited to the addicted person. Infectious 
diseases have a greater impact on society, since they have the ability to be passed on to 
other individuals.  
HIV is a blood borne pathogen that can progress to acquired immunodeficiency 
syndrome (AIDS).  HIV/AIDS works to destroy white blood cells, in particular T cells. 
This destruction ultimately disables the immune system of the human body leaving the 
infected individual vulnerable to other illnesses (CDC, 2008).  HIV /AIDS is spread 
through blood and other body fluids. This is especially a concern for intravenous drug 
users (IDUs).  IDUs use needles to administer drugs, sometimes sharing needles. Sharing 
contaminated needles is a well-known mode of transmission of HIV/AIDS, as well as 
hepatitis C.  According to the CDC, since the AIDS epidemic began, injection drug use 
has directly and indirectly accounted for 36% of AIDS cases in the United States.  
Hepatitis C can also be a devastating illness. Hepatitis C is a viral disease that 
causes liver damage. It is spread primarily through contact with blood. IDUs are again at 
risk for contracting this disease and spreading it to others.  According to a study 
conducted by the NIDA, within one year of injecting drugs, 64.7% of IDUs contracted 
hepatitis C. Hepatitis C was found in 76.5% of IDUs who had been injecting drugs for 6 
years or less (NIDA, 2008).  Among addicts, the spread of HIV/AIDS and hepatitis C has 
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been traditionally associated with injection drug use, however, according to the CDC, any 
drug including alcohol can lead to poor judgment and risky behavior. This risky behavior 
puts addicts at risk for contracting HIV and other sexually transmitted diseases. Drug use 
can lead to harmful personal health consequences as well as propel the spread of 
infectious diseases within the entire community.  
 
Criminal Effects 
According to the Federal Bureau of Investigation, in 2006, there were a total of 
1,376,792 state and local arrests for drug abuse violations.  In 2004, 17% of state 
prisoners and 18% of federal inmates said they committed their current offense to obtain 
money for drugs (Crime in the United States, 2007).  To further illustrate the role drugs 
play in crime, in 2005, there were 5.2 million violent victimizations of US residents aged 
12 or older. When victims were asked to describe whether or not their assailant was under 
the influence of drugs, approximately 27% of the victims of violence reported that the 
offender was using drugs or alcohol (National Crime Victimization Survey, 2005).   
The cost of drugs on society is also high. Studies estimate the societal cost of drug 
abuse in the United States to be $143.4 billion in 1998. The majority of these costs are 
productivity losses, particularly those related to incarceration, crime careers, drug abuse 
related illnesses, and premature death. The overall cost of drug abuse rose 5.9 % annually 
between 1992 and 1998 increasing from $102.2 to $143.4 billion. This increase was 
primarily due to the increase in productivity losses related to incarceration and drug 
abuse related illnesses ( ONDCP, 2001). Drug addiction plays a large role in criminal 
activity. Addicts are often willing to risk their freedom to obtain drugs. 
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Treatment 
 
 
Treatment is essential in the recovery of an addicted individual. Recovery is 
defined by the Betty Ford Institute as “ a voluntarily maintained lifestyle characterized by 
sobriety, personal health, and citizenship”. There are a variety of treatment options 
available for recovery, although some treatment programs may be more effective for 
certain individuals than others. 
 According to the Office of National Drug Control Policy (ONDCP) a good 
treatment program attends to the multiple needs of the individual, not just his or her drug 
use.  Treatment must work to mend all areas that drug use disrupts, from psychological 
and social issues to vocational issues. According to the NIDA’s Principles of Drug 
Addiction Treatment: A Research Based Guide, published in 2000, there are “thirteen 
principles of effective treatment”. These principles were developed in order to guide 
those involved in treatment plans to create effective programs. They cover a wide range 
of issues that an addict may face on the path to recovery. The thirteen principles are 
outlined below. 
 
Principles of Effective Treatment (NIDA, 2000) 
1. No single treatment is appropriate for all individuals. Matching treatment settings, 
interventions, and services to each individual's particular problems and needs is critical to his or 
her ultimate success in returning to productive functioning in the family, workplace, and society.  
2. Treatment needs to be readily available. Because individuals who are addicted to drugs may 
be uncertain about entering treatment, taking advantage of opportunities when they are ready 
for treatment is crucial. Potential treatment applicants can be lost if treatment is not immediately 
available or is not readily accessible.  
3. Effective treatment attends to multiple needs of the individual, not just his or her drug 
use. To be effective, treatment must address the individual's drug use and any associated 
medical, psychological, social, vocational, and legal problems.  
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4. An individual's treatment and services plan must be assessed continually and modified 
as necessary to ensure that the plan meets the person's changing needs. A patient may 
require varying combinations of services and treatment components during the course of 
treatment and recovery. In addition to counseling or psychotherapy, a patient at times may 
require medication, other medical services, family therapy, parenting instruction, vocational 
rehabilitation, and social and legal services. It is critical that the treatment approach be 
appropriate to the individual's age, gender, ethnicity, and culture.  
5. Remaining in treatment for an adequate period of time is critical for treatment 
effectiveness. The appropriate duration for an individual depends on his or her problems and 
needs. Research indicates that for most patients, the threshold of significant improvement is 
reached at about 3 months in treatment. After this threshold is reached, additional treatment can 
produce further progress toward recovery. Because people often leave treatment prematurely, 
programs should include strategies to engage and keep patients in treatment.  
6. Counseling (individual and/or group) and other behavioral therapies are critical 
components of effective treatment for addiction. In therapy, patients address issues of 
motivation, build skills to resist drug use, replace drug-using activities with constructive and 
rewarding non-drug-using activities, and improve problem-solving abilities. Behavioral therapy 
also facilitates interpersonal relationships and the individual's ability to function in the family and 
community.  
7. Medications are an important element of treatment for many patients, especially when 
combined with counseling and other behavioral therapies. Methadone and levo-alpha-
acetylmethadol (LAAM) are very effective in helping individuals addicted to heroin or other 
opiates stabilize their lives and reduce their illicit drug use. Naltrexone is also an effective 
medication for some opiate addicts and some patients with co-occurring alcohol dependence. For 
persons addicted to nicotine, a nicotine replacement product (such as patches or gum) or an oral 
medication (such as bupropion) can be an effective component of treatment. For patients with 
mental disorders, both behavioral treatments and medications can be critically important.  
8. Addicted or drug-abusing individuals with coexisting mental disorders should have 
both disorders treated in an integrated way. Because addictive disorders and mental 
disorders often occur in the same individual, patients presenting for either condition should be 
assessed and treated for the co-occurrence of the other type of disorder.  
9. Medical detoxification is only the first stage of addiction treatment and by itself does 
little to change long-term drug use. Medical detoxification safely manages the acute physical 
symptoms of withdrawal associated with stopping drug use. While detoxification alone is rarely 
sufficient to help addicts achieve long-term abstinence, for some individuals it is a strongly 
indicated precursor to effective drug addiction treatment.  
10. Treatment does not need to be voluntary to be effective. Strong motivation can facilitate 
the treatment process. Sanctions or enticements in the family, employment setting, or criminal 
justice system can increase significantly both treatment entry and retention rates and the 
success of drug treatment interventions.  
11. Possible drug use during treatment must be monitored continuously. Lapses to drug use 
can occur during treatment. The objective monitoring of a patient's drug and alcohol use during 
treatment, such as through urinalysis or other tests, can help the patient withstand urges to use 
drugs. Such monitoring also can provide early evidence of drug use so that the individual's 
treatment plan can be adjusted. Feedback to patients who test positive for illicit drug use is an 
important element of monitoring.  
12. Treatment programs should provide assessment for HIV/AIDS, hepatitis B and C, 
tuberculosis and other infectious diseases, and counseling to help patients modify or 
change behaviors that place themselves or others at risk of infection. Counseling can help 
patients avoid high-risk behavior. Counseling also can help people who are already infected 
manage their illness.  
13. Recovery from drug addiction can be a long-term process and frequently requires 
multiple episodes of treatment. As with other chronic illnesses, relapses to drug use can occur 
during or after successful treatment episodes. Addicted individuals may require prolonged 
treatment and multiple episodes of treatment to achieve long-term abstinence and fully restored 
functioning. Participation in self-help support programs during and following treatment often is 
helpful in maintaining abstinence.  
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According to the principles, in order to be effective, a treatment program must first 
recognize that one method is not always good for all individuals.   A program must 
address the multiple needs of an addict, continually assess the addict and his or her goals, 
explore counseling and medication in treatment, address health issues both mental and 
physical, as well as recognize the need for self-support programs to help maintain 
abstinence from drug use by an addict. 
 
Types of Treatment  
As mentioned, a variety of scientifically based approaches to drug addiction 
treatment exist. Drug addiction treatment can include behavioral therapy (such as 
counseling, cognitive therapy, or psychotherapy), treatment with medication, or a 
combination of the two (NIDA, 2008).  
There are many treatment options, such as outpatient treatment services, twelve-
step programs, short-term residential programs, drug courts and long-term residential 
treatment centers. All of these options display varying degrees of success. With the 
exception of heroin, treatment programs are not defined by a person’s addiction. All 
addicts, whether they are addicted to cocaine, marijuana or some other substance, usually 
participate in the same type of treatment programs. 
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Medical Detoxification 
 
 
Detoxification is the process in which a person is taken off the drugs and/or 
alcohol in which he or she has become physically dependent (Emmelkamp and Vedel, 
2006).  Detoxification is performed under the care of a physician, and can be done 
abruptly or slowly (NIDA, 2008).  Most treatment plans consider detoxification as a 
precursor or medical intervention that is necessary before beginning a formal treatment 
program.  Medications may be necessary to assist an individual in the detoxification 
process, especially since some drugs, such as heroin, have physical withdrawals (NIDA, 
2008). An assessment was done on a 1980 opiate detoxification study conducted by 
Simpson and Sells.  This opioid study consisted of 4,267 interviews and assessed various 
methods of detoxification. Barry Stimmel evaluated this study in the Evaluation of Drug 
Treatment Programs: Advances in Alcohol and Substance Abuse. Stimmel and his 
associates found that although detoxification is essential in the process of treatment and 
recovery, it is only a temporary state. The evaluation reveals that without an overall 
rehabilitation program, detoxification has no proven long-term effects on drug 
dependence (Stimmel, 1983). 
 
Outpatient treatment programs or Outpatient Non-Methadone Treatment 
 
Outpatient treatment costs less than residential or inpatient treatment programs, 
and is often more suitable for those who are employed or have a large amount of social 
support.  Outpatient treatment programs are considered low-intensity and may offer at 
most drug education and reprimands for using illegal drugs (NIDA, 2008). 
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Outpatient treatment programs usually last around 10 weeks.  Programs may take 
place in 2 to3 hour sessions over a few days per week.   Although outpatient treatment 
programs are not as intense as inpatient or residential treatment options, these programs 
do include a psychological assessment, the development of treatment plans, and 
rehabilitation.  Overall, rehabilitation seeks to modify an individual's behavior through 
individual and group therapy, peer assessment and support groups.  Drug tests may also 
be administered within an outpatient setting to monitor the participant’s progress. Testing 
is important since participants are not confined to the treatment center and may have 
access to drugs in the community (NIDA, 2008). 
A 1999 survey published in the Drug Abuse and Outcome Studies (DATOS) 
shows that outpatient drug free treatment can have a positive effect on decreasing drug 
use.  In the survey, researchers found a 57% drop in the number of weekly cocaine use, a 
64% reduction in the number of weekly marijuana use, and a 52% decline in heavy 
drinking. Illegal activities decreased by 36%.  Twenty percent of participants were 
referred to follow-up treatment.  Studies indicate that the longer a patient stays the better 
the outcomes.  An analysis, published in the Treatment Outcome Prospective Study 
(TOPS) in the 1980’s, showed that the critical retention threshold for recovery is 
approximately 6 months for outpatient therapy. However, only 17% of participants at that 
time remained in treatment for 6 months. On average, most outpatient programs do not 
last 6 months.  It seems that although outpatient treatment is beneficial, it does not have a 
high retention rate after the 6-month mark. Additionally, a 6-month outpatient program 
may not even be offered in some areas. The low retention rate shown by TOPS suggests 
an increased chance of relapse among participants in outpatient treatment programs. This 
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study implies that there could be a more effective method, besides outpatient treatment, 
for some addicts. 
 
Twelve-Step Programs 
Twelve-step programs can work in conjunction with or without outpatient 
treatment programs.  Traditional twelve-step programs such as Alcoholics Anonymous 
(AA) are group-structured therapies. Therapeutic processes are embedded within the 
steps. Under a twelve-step program, individuals develop methods for self-regulation, 
increase their sense of self-efficacy, improve relationships with others, and identify their 
vulnerabilities. Participants also learn how to work and cope within stressful situations 
without turning to alcohol or drugs.   Research has suggested that those in involved in 
twelve-step programs, such as AA, are more likely to use a variety of therapeutic or 
adaptive processes, avoid negative situations, actively use coping skills, and become less 
reliant on drinking or drugs for comfort.  Although twelve-step programs can be effective 
in decreasing drug dependence, they may not always be helpful to everyone.  Evidence 
has shown that with participation in the program, some individuals may experience an 
increase in guilt, increased drug use and poor improvement with family and friends( 
Galanter and Kleber, 2004). This again shows that not all treatment programs are for 
everyone, and that other options should be explored to better serve an addicted 
individual. 
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Short-Term Residential Programs 
 
Short-term residential programs are modified twelve-step programs that are 
primarily oriented toward insured populations (Galanter and Kleber, 2004). Short-term 
residential programs are usually structured around a 3-6 week inpatient program in which 
patients do not leave the treatment facility. Upon arrival to the program, patients are 
assessed and a recovery plan is developed. This recovery plan usually is based on the 
twelve-steps of recovery.  Lectures and required Alcoholic Anonymous - type meetings 
are required of the residents.  A 1999 study by DATOS showed that in a survey of short-
term inpatient/residential treatment programs there was a 69% decrease in weekly 
cocaine use, a 63% decrease in weekly marijuana use and a 58% decrease in heavy 
weekly alcohol use. Although these statistics do show success in reducing the use of 
drugs and alcohol, researchers warn that since most short-term residential programs are 
funded by private insurance companies, the results could be biased (DATOS, 1999).  
Another disadvantage to short-term residential treatment programs is that they are 
becoming less available to addicts due to reduced health care coverage.  Lack of funding 
is also causing a decrease in the average length of stay, making this type of program less 
useful to addicts. So, even though short-term residential programs are beneficial in 
getting patients started in the process of recovery, they are primarily private and are 
becoming less available due to health care coverage restraints. 
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Community-Based Treatment for Criminal Justice Populations  
 
 
Another option for treatment comes from court mandated treatment programs. 
These programs are designed to send offenders with drug use convictions into treatment 
programs rather than to jail.  Under this program, offenders are mandated to a treatment 
facility, where they are monitored. They are treated within a community setting where 
they receive counseling, medical care, and job training.  Those who are mandated to drug 
court must remain in the program or face other legal issues. Success has been seen with 
this type of treatment.  A 2002 National Institute of Justice study of 2,020 graduates from 
95 drug courts in 1999 and 2000 showed that after graduation, only 16.4 % of drug court 
graduates had been arrested and charged with a serious offense after one year and 27.5 % 
at the two - year mark. This type of treatment is worth mentioning because of its success, 
however, it is limited to those who commit offenses and who live in areas where drug 
courts are offered. 
 
Long –Term Residential Treatment/Therapeutic Communities 
Long-term residential treatment programs or therapeutic communities provide 
care 24 hours a day on an on-campus residential setting. Lengths of stay can be anywhere 
from 6 months to 24 months. There are various components of a therapeutic community, 
most of which mirrors principle three of the Effective Principles of Treatment, outlined 
by the NIDA. Principle three states that a good treatment program attends to all of the 
needs of the addict, from mental to vocational needs. This is what a therapeutic 
community does; it treats the whole person, not just the disease. In fact, therapeutic 
communities have shown a large amount of success and have the lowest rate of relapse or 
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need for further treatment than other methods. This is especially true of prison based 
therapeutic communities and outside therapeutic communities for recently paroled 
inmates. Among these populations, rates of recidivism are significantly lower than with 
traditional methods of treatment (Chanhatasilpa, Mackenzie, and Hickman, 2000). 
Therapeutic communities are drug-free residential settings that address all levels of 
personal and social responsibility. Participants are given the chance to re-learn personal 
and social responsibilities through peer-mediated groups. Many of those admitted to 
therapeutic communities have lost jobs, friends and family due to their substance 
dependence. Others have had a long history of difficulty functioning within society. The 
therapeutic community works to rehabilitate individuals and train those vocationally and 
socially who have had difficultly achieving success due to drug and alcohol dependence. 
During peer meetings, residents are forced to face their negative and sometimes 
destructive behavior. They are taught and encouraged to adopt better, more constructive 
ways of handling stressful situations without using drugs (NIDA, 2008).  
According to a 1999 DATOS one - year follow-up survey on alcohol and drug 
dependence, long-term treatment programs showed the greatest success in the reduction 
of daily cocaine use by individuals. Those who participated in long-term treatment 
programs showed a 12 % drop in daily cocaine use, while those who participated in 
outpatient programs showed a 9% decrease in daily cocaine use. There was an 8% drop in 
daily cocaine use for those in short-term residential programs. Additionally, 40 % of 
those who used short-term treatment programs relapsed to weekly cocaine use compared 
to 28% of those who had long-term stays. Overall, the study shows the most success with 
long-term treatment programs or therapeutic communities, with an overall drop of weekly 
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cocaine use of 67% and a decrease in weekly heavy alcohol use of 53%. Additionally, 
unemployment dropped 13% and illegal acts dropped 61%.  Although the percentages are 
somewhat comparable to those of short-term programs, long-term programs have higher 
success rates, are more readily available to addicts, and are not dependent upon insurance 
to cover costs.   
 
 
 
Conclusion 
 
Drug addiction is a chronic disease that can lead to severe ramifications in an 
affected person's life.  Not only can drug addiction lead to poor health or even death, but 
it can also lead to the loss of family, friends, careers and freedom.  Addiction can begin 
as a curiosity and the occasional use of a substance, but can quickly progress into 
something more detrimental. Once addicted, a person often sacrifices the things that are 
most important to him or her just to satisfy the need for a drug.  Once a person has 
progressed to addiction, treatment is the primary option for getting someone into a 
healthy lifestyle.  There are many treatment options available, but only those that 
primarily follow the principles of effective treatment, outlined by the NIDA, will offer 
the most success. Of these options, therapeutic communities appear to be the best method 
of treatment for an addict. In a community setting, the individual has the opportunity to 
re-learn social and behavioral skills as well as gain educational and further vocational 
training. Individuals learn how to become a drug free, productive person again. 
 As mentioned earlier, statistics have shown that individuals that participate in 
long-term programs, whether inside the community or through prison based therapeutic 
communities, have the lowest need for follow-up treatment and the highest success rates. 
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Criminal offenders in these programs have the lowest recidivism rates than offenders in 
other treatment programs.  Treatment will help to heal the lives of addicts, allowing them 
to acquire the skills to live drug free. With treatment, criminal activity will decrease and 
addicts may be able to regain some of their social and economic stability. From a public 
health perspective, treatment will work to decrease usage among addicts, improving 
personal health and reducing the spread of infectious diseases. In this manner, treatment 
will not only benefit the health of addicts, but also the health of the entire community.   
When choosing a treatment program, it is important to remember that all 
programs do not fit everyone’s lifestyle. Some addicts may not respond as well to some 
treatments as others do. Some methods may not meet all of the needs of an addict. 
However, of all the treatment programs, therapeutic communities appear to meet the 
multiple needs of addicts. Therapeutic communities not only meet the mental needs but 
also the social, vocational and educational needs. Although any treatment is better than 
not having treatment, therapeutic communities appear to be the best method for the 
sustained, long-term recovery of addicts.  
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